Related Experiment Video
Updated: Mar 31, 2026

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
Published on: November 23, 2013
Acute Pediatric Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-Associated Rhombencephalitis With Multifocal Brain
Ruilin Wang1, Jessica N Smock1, Anusri Pakhare2
1Osteopathic Medicine, Nova Southeastern University Dr. Kiran C. Patel College of Osteopathic Medicine, Fort Lauderdale, USA.
Abstract:
Rhombencephalitis is a rare inflammatory condition involving the brainstem, with both infectious and autoimmune causes. While infections account for many pediatric cases, autoimmune etiologies such as myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) have gained wider recognition. We present a six-year-old male with no significant past medical history who presented with acute-onset ataxia, dysarthria, olfactory hallucinations, and headache with associated intermittent fever. Cerebrospinal fluid (CSF) analysis revealed leukocytosis with increased lymphocytes and monocytes, but negative infectious studies. Two days after the patient initially presented, brain magnetic resonance imaging (MRI) revealed findings suggestive of autoimmune rhombencephalitis. After administration of intravenous (IV) methylprednisolone and IV immunoglobulin G (IgG), the patient's condition drastically improved. Due to laboratory processing timelines, the myelin oligodendrocyte glycoprotein antibody (MOG-IgG) resulted positive 10 days after the patient's initial presentation and five days after the patient had clinically returned to baseline and been discharged. MOGAD in children is known to have a variety of clinical presentations, and delayed antibody test results should not postpone initiation of acute immunosuppressive therapy. Acute treatment should be initiated based on clinical and radiological suspicion to prevent persistent neurological deficits and risk of long-term disability.
Insights
Autoimmune rhombencephalitis, including myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), requires prompt treatment. Early treatment based on clinical and imaging findings is crucial for children with MOGAD, even with delayed antibody results.
Area of Science:
- Neurology
- Immunology
- Pediatrics
Background:
- Rhombencephalitis is a rare brainstem inflammation with infectious and autoimmune causes.
- Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is an increasingly recognized autoimmune etiology, particularly in children.
- Pediatric rhombencephalitis often presents with diverse neurological symptoms.

